STOP! - Senior Sales Representative bei Genentech: Mitarbeiterbewertung

2.0
2. Juli 2020
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Father of BioOncology. Created targeted oncology and hematology products that changed the course of the disease.

Kontras

Will never be DNA again. Massive layoffs of long term highly skilled employees over the past six years (60+%). The departure of early and late-stage researchers has impacted future opportunities. They "don't need people managers." Little to no support from HR for retaliation and bad managers. No exit interviews. No action is taken to protect employees—multiple civil suits.

Mehr Bewertungen zu Genentech entdecken

5.0
27. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Patient-centric company. great culture & benefits

Kontras

Not always clear how promotions are awarded.

2.0
19. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The work is meaningful and overall the company vision aligns with my goals

Kontras

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle